Archived from the original on 4 April 2017
Vila-Viosa, D., Teixeira, V
These injections combine essential nutrients that work together to enhance fat metabolism, boost energy levels, and support overall wellness
- Chit xut rau m, lu , hoa hng,
Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic